If you’ve ever tried to offer Ketamine-Assisted Psychotherapy (KAP) in your practice or looked for a ketamine prescriber for one of your clients, you’ve probably discovered something surprising:
It’s incredibly difficult to find a psychiatrist or medical provider willing to prescribe ketamine, even for a shared patient.
Clinicians often assume this is because ketamine is “controversial,” or because prescribers simply don’t believe in the modality. But the real reasons are much more complex. This is what makes finding a KAP prescriber near you very tough.
In this article, we will discuss some of the top reasons why it’s hard to find a KAP prescriber near your location and also what you can do about it. If you are a patient, pay attention to this blog, and if you are a clinician looking for a KAP prescriber partnership, you will find one by the end of this article.
Here’s what’s actually going on underneath the surface.
Most Local Psychiatrists Will Not Prescribe Ketamine — Even for Their Own Clients
Many people sometimes assume that if ketamine is legal and increasingly researched, prescribing it should be straightforward. In reality, most local psychiatrists choose not to prescribe ketamine, even for long-term clients they know well. This hesitation is less about disbelief in ketamine’s potential and more about how incompatible it is with the traditional psychiatric model.
It requires significant oversight
Ketamine can cause dissociation, perceptual changes, and emotional activation.
Prescribers must feel confident that patients are safe, supported, and clinically appropriate — which requires:
- screening for trauma
- assessing for dissociation
- understanding dosing distinctions
- monitoring ongoing response
- coordinating with the therapist
Most psychiatrists are not trained in psychedelic-assisted care, so the responsibility feels too high. Ketamine does not function like a standard antidepressant; it opens psychological material that must be held within a therapeutic container. Without training or collaborative infrastructure, prescribers are left carrying clinical risk alone.
It’s a controlled substance
Even though ketamine is legal, it is still regulated. Prescribers worry about:
- DEA scrutiny
- misuse or diversion
- the optics of prescribing ketamine
- unclear long-term protocols
For many, it feels like stepping into a grey zone they were never trained for. Traditional psychiatric education offers little guidance on navigating altered states within ethical, regulatory, and relational boundaries.
Liability concerns are enormous
Unlike SSRIs, prescribing ketamine means entering a therapeutic space that includes:
- altered states
- trauma activation
- potential emotional regression
- in-session risk factors
To prescribe safely, patients need a KAP therapist they trust, communication systems, and a shared treatment protocol and plan. Most communities simply don’t have that infrastructure. This gap explains why ketamine-assisted psychotherapy cannot function safely inside isolated, medication-only models.
Ketamine Entered the Market in a Way No One Expected
Most psychiatric medications follow a slow, highly regulated path into mainstream care. Ketamine did not. Instead, it emerged through a series of rapid developments that left much of the mental health field struggling to keep pace.
- IV clinics opened overnight
Standalone infusion clinics began offering ketamine outside of traditional psychiatric settings, often without integrated psychotherapy or long-term treatment frameworks.
- Marketing campaigns exploded
Ketamine was quickly framed as a breakthrough or fast solution, shaping public perception before clinical consensus had time to form.
- The FDA approved Spravato
In 2019, the FDA approved esketamine (Spravato), signaling institutional legitimacy while simultaneously blurring distinctions between medication-only models and therapy-supported care.
- Patients started asking about it daily
Demand surged, often outpacing prescribers’ training, comfort, and understanding of appropriate clinical use.
- Therapists became curious
Clinicians recognized ketamine’s potential for depth work, trauma processing, and treatment-resistant depression.
- The entire field had no time to adjust
Education, ethics, and infrastructure lagged behind access.
Many prescribers were genuinely shocked that ketamine could be used off-label for mental health, let alone paired with psychotherapy. This rapid, unstructured entry left clinicians unsure, and understandably hesitant, about how to engage safely and responsibly.
Lack of Education = Lack of Comfort
Most medical training programs include little to no education on psychedelics or ketamine-assisted psychotherapy. Psychiatry residencies are largely structured around medication management models that emphasize symptom reduction, standardized dosing, and brief follow-up visits. Altered states of consciousness, trauma activation, and experiential therapies are rarely part of formal curricula.
As a result, prescribers who are curious about ketamine must seek education independently. This often includes psychedelic medicine training, KAP-specific education, experiential learning, consultation groups, and ongoing ethical, legal, and safety training. None of this is required, standardized, or easily accessible within traditional systems.
Without this foundation, prescribing ketamine can feel like stepping into unfamiliar and potentially risky territory. The clinical demands are different, the responsibilities feel heavier, and the margin for error feels smaller.
For many prescribers, choosing not to enter the space at all feels like the safest option, not because ketamine lacks potential, but because adequate training and support have historically been absent.
Overhead and Infrastructure Are a Major Barrier
Even psychiatrists who are interested in prescribing ketamine often find themselves unable to implement treatment. The logistical and operational demands are significant, and setting up a safe, compliant KAP practice requires substantial preparation.
Ketamine treatment involves multiple components that go beyond traditional medication management, including:
- Malpractice insurance extensions
- Specialized documentation
- Practice-wide safety protocols
- Collaboration systems with therapists
- Time-intensive communication
For prescribers accustomed to 15-minute med-management sessions, integrating KAP can feel like building a mini-clinic within an existing practice. Every session demands careful monitoring, coordination, and follow-up, requiring time and resources most traditional offices simply do not have. This infrastructure barrier is one of the main reasons many psychiatrists do not offer ketamine treatment.
Most Prescribers Don’t Want to “Go It Alone”
Ketamine-Assisted Psychotherapy is not a treatment a prescriber can offer in isolation. Unlike traditional medication management, KAP requires an active, ongoing partnership with a therapist, not just a signature on a prescription.
Safe and effective care depends on shared treatment plans, regular clinical updates, access to session summaries, coordinated dosing adjustments, and a mutual understanding of therapeutic goals. Without this level of collaboration, prescribers are left making decisions without adequate context.
In reality, most prescribers do not have a network of KAP-trained therapists they know and trust. At the same time, many therapists interested in KAP struggle to find prescribers who are informed, open, and willing to collaborate.
So even when the clinical interest exists, the supporting infrastructure often does not, making isolated prescribing feel unsafe and unsustainable.
So… Where Does That Leave Clinicians Looking for a KAP Prescriber?
For many clinicians, the challenge isn’t a lack of interest or training. It’s the absence of a viable prescribing partner. This gap in the field is exactly why many therapists feel stuck:
- You want to offer KAP
- Your client is a good candidate
- You have clinical training
- But you cannot find a prescriber who will partner with you
Existing options rarely solve this problem in a meaningful way. IV clinics don’t solve this:
- They don’t collaborate with psychotherapists
- They often don’t include therapy
- They are costly
- There is minimal aftercare
National prescribing platforms address medication access, but not the therapeutic relationship, clinical collaboration, or professional community that KAP requires. As a result, clinicians are left without the infrastructure needed to practice safely and ethically.
The Ko-Op Exists Because This Gap Exists
The Ko-Op was created to address the very real gap clinicians face when trying to practice Ketamine-Assisted Psychotherapy responsibly. Rather than asking therapists or prescribers to work in isolation, we built an infrastructure that supports collaboration, safety, and clinical depth.
We provide:
→ A trusted prescriber partnership
Prescribers within The Ko-Op are trained in KAP and work in direct collaboration with therapists. This relationship allows for informed prescribing grounded in the therapeutic process, not detached decision-making.
→ Clear communication structure
Treatment planning is shared between therapist and prescriber, ensuring alignment around clinical goals, dosing considerations, and client readiness throughout the course of care.
→ Ethical + clinical oversight
Every client’s plan is reviewed thoughtfully and intentionally. Care is never “automatically approved,” and screening, safety, and appropriateness remain central.
→ Community consultation
Clinicians meet in consistent consultation groups weekly or biweekly, fostering trust, shared learning, and increased clinical confidence over time.
→ All legal and clinical materials
Consent forms, documentation, protocols, and risk frameworks are provided, allowing clinicians to focus on care rather than administrative burden.
→ A boutique, relationship-based model
The Ko-Op is not a national platform, a medication mill, or a detached prescribing service. It is a real clinical community built on relationships, communication, and care.
Final Thoughts
Finding a KAP prescriber is always hard. This isn’t because you did something wrong, but it can be the case due to multiple reasons. However, the fact that the field is relatively new, complex, and full of gaps is cause enough.
You always need a KAP prescriber partnership to practice and execute the medication intake safely. If you still haven’t found someone, The Ko-Op can help you. Our in-house prescribers help patients handle medication guidance while providing oversight during sessions.
To partner with The Ko-Op, you can reach out to us here.
To start exploring a KAP prescriber, click here.
